DINAQOR
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure. Its lead preclinical program, DiNA-001, is focused on the treatment of MYBPC3-linked cardiomyopathy. DiNAQOR was founded in 2019 and is headquartered in Pfäffikon, Switzerland.
DINAQOR
Industry:
Biotechnology Health Care Medical
Founded:
2019-04-01
Address:
Pfäffikon, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.dinaqor.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Activaero
Activaero develops breathing technologies for patients suffering from severe respiratory diseases.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
FABPulous
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-19 | EHT Technologies | EHT Technologies acquired by DiNAQOR | N/A |
Official Site Inspections
http://www.dinaqor.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: summer.metanet.ch
- IP address: 80.74.149.100
- Location: Neunkirch Switzerland
- Latitude: 47.6901
- Longitude: 8.4998
- Timezone: Europe/Zurich
- Postal: 8213
More informations about "DiNAQOR"
About Us - DiNAQOR
DiNAQOR is a life sciences platform company that is pioneering proprietary human-based tissue drug development and technology to enable organ-specific delivery of gene therapies and …See details»
DiNAQOR – Bringing Gene Therapy to the Failing Heart
Jan 9, 2023 DiNAQOR partners with Siegfried to scale and commercialize DiNAMIQS as a best-in-class development and manufacturing platform for cell and gene therapies Read More DiNAQOR is a life sciences platform company …See details»
DiNAQOR - Crunchbase Company Profile & Funding
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy …See details»
DiNAQOR: Contact Details and Business Profile - RocketReach
DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic. Our patent-protected, …See details»
Company Overview - DiNAQOR
Permitted without prior consent by DiNAQOR. 3 OUR MISSION. To bring gene therapy to the failing heart. 3. 4 Heart failure is a serious disease and a leading cause of death. Sources: …See details»
DiNAQOR AG – Swiss Biotech
DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development. ... Type of organization. Private company. Year of …See details»
The DiNAQOR group: a disruptive holistic approach to …
With its innovative modular technology platform and fully integrated organizational approach, DiNAQOR AG is progressing the development and delivery of therapies for devastating genetic diseases ...See details»
DiNAQOR AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore DiNAQOR AG with its drug pipeline, therapeutic area, technology platform, 2 news, Technology Platform:AAV based gene therapy, Gene therapy, Gene editing, Drug ...See details»
DiNAQOR - Funding, Financials, Valuation & Investors - Crunchbase
Jan 19, 2021 DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. ... Solutions. Products. Resources. Pricing. …See details»
DiNAQOR AG Company Profile | Schlieren, ZÜRICH, Switzerland ...
Find company research, competitor information, contact details & financial data for DiNAQOR AG of Schlieren, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Dinaqor Company Profile 2024: Valuation, Funding & Investors
Dinaqor General Information Description. Developer of gene therapies focused on advancing novel solutions for heart diseases. The company offers genetic medicines and capsids for …See details»
Management – DiNAQOR
DiNAQOR was founded and is led by several leading pharmaceutical and biotechnology executives and academics with deep cardiology and gene therapy expertise. Johannes …See details»
DiNAQOR - Contacts, Employees, Board Members, Advisors
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. Search Crunchbase. Start Free Trial . Chrome …See details»
DiNAQOR - Overview, News & Similar companies | ZoomInfo.com
May 15, 2022 Founded in 2019, DiNAQOR AG is a global gene therapy platform company focused on advancing novel solutions for patients suffering from heart diseas e. The …See details»
DiNAQOR - Company info. interviews, news
DiNAQOR is a global gene therapy platform company focused on advancing novel solutions for patients suffering from heart disease. We are headquartered in Pfäffikon, Switzerland, with …See details»
DiNAQOR Company Overview, Contact Details & Competitors
DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic. Our patent-protected, …See details»
DiNAQOR - VentureRadar
DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing …See details»
DiNAQOR Appoints Two Seasoned Executives to Leadership Team
Jan 9, 2023 He comes to DiNAQOR from the PKD Foundation, a not-for-profit organization dedicated to finding treatments and a cure for polycystic kidney disease (PKD). He also served …See details»
Dinaqor | CipherBio
Explore Dinaqor's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Chris Rusconi, PhD – DiNAQOR
Dr. Rusconi joins DiNAQOR from the PKD Foundation, a not-for-profit organization dedicated to finding treatments and a cure for polycystic kidney disease (PKD). He also served as the Chief …See details»